|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/77 | |
| A61P 9/04 |
| (11) | Number of the document | 2046348 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07810983.2 |
| Date of filing the European patent application | 2007-08-01 | |
| (97) | Date of publication of the European application | 2009-04-15 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/017182 |
| Date | 2007-08-01 |
| (87) | Number | WO 2008/016640 |
| Date | 2008-02-07 |
| (30) | Number | Date | Country code |
| 834728 P | 2006-08-01 | US |
| (72) |
MARKHAM, Bruce Edward, US
|
| (73) |
Phrixus Pharmaceuticals, Incorporated,
300 North Fifth Avenue Suite 150, Ann Arbor, MI 48104,
US
|
| (54) | USE OF POLOXAMER FOR THE PREVENTION AND/OR TREATMENT OF HEART FAILURE |
| USE OF POLOXAMER FOR THE PREVENTION AND/OR TREATMENT OF HEART FAILURE |